A New Antibody For Treating Acute Lymphocytic Leukemia?

Of all the drugs being discussed at this year’s meeting of the American Society of Hematology, one caught my attention. The new agent, a monoclonal antibody to CD22 with a toxin attached, is manufactured by Pfizer. It’s called inotuzumab ozogamicin. As that’s a mouthful, some doctors call it Ino. Last summer [...]

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

American Society of Hematology [+]    Pfizer [+]    Ino [+]   

More #news: